Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Oct. 12, 2018. Deborah Kotz.

Executive Summary

US FDA hasn't posted a device-related close-out letter online in five months. Agency spokeswoman Deborah Kotz says firms were "issued" close-outs over the past six months – they just haven't been posted online yet. But a firm being "issued" a close-out letter isn't the same as having FDA publicly announce it online for the world to see – which, one could argue, is the whole reason behind the close-out program in the first place. See what else Kotz said here.

"There has been no change to our policy or process for issuing warning letter close-out letters. Close-out letters have been consistently issued over the past six months at the same rate as they were issued for the six months prior to that. We are aware that the warning letter close-out webpage is not up-to-date, and we are working to resolve the issue." –Deborah Kotz, spokeswoman, US FDA

Click here for a free trial of Medtech Insight

 

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123413

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel